CK 3197
Alternative Names: CK-3197Latest Information Update: 22 Jan 2007
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Cardiotonics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 22 Jan 2007 Discontinued - Preclinical for Heart failure in USA (unspecified route)